...cer Drug Targets, 2005, 5, 149-157149EphA2 Receptor Tyrosine Kinase as a Promising Target for CancerTherapeuticsReneé C. Ireton1 and Jin Chen*,1,2,3,41Department of Medicine, Division of Rheumatology and Imm...
NUCLEICACIDTHERAPEUTICSVolume24,Number4,2014ªMaryAnnLiebert,Inc.DOI:10.1089/nat.2014.0480DevelopmentofRNAInterference–...
Alzheimer’s Disease: Genetics, Pathogenesis, Models, and Experimental Therapeutics
...CellStemCellProtocolReviewHumanPluripotentStemCellCulture:ConsiderationsforMaintenance,Expansion,andTherapeuticsKevinG.Chen,1,*BarbaraS.Mallon,1RonaldD.G.McKay,2andPamelaG.Robey3StemCellUnit,NationalInstituteofNe...
21 0第 3 0年 1卷第 7期信息【球医药快讯】全 欧盟批准安进公司 d n sma e ou b上市21 0 0年 5月,安进公司 ( Amgn宣布欧盟委员会已 e) F A批准 Gln r D e ma k公司仿制避孕药上市 21 0 0年 5月,总部位于印度孟买的 Gl mak制药公司 e r n宣布其美国分公司收到了 F A对于其 03 D .5mg炔诺酮片剂的简易新药申请的批准函。 ...
... Inc., a clinical stage biotechnology company, is engaged in the discovery and development of novel therapeutics that modulate immune responses through toll-like receptors (TLRs)in the United States. The company’...
...ansition,suppressingtumorangiogenesis,anddownregulatingef uxtransporters.ThedevelopmentofmiRNA-basedtherapeuticsincombinationwithsmall-moleculeanticancerdrugsprovidesanunprecedentedopportunitytocounteractchemores...
...VEDGESUBSYSPROPRIETARY NAMEESTABLISHED NAMEFENTANYLARGATROBANSODIUM CHLORIDEDOCETAXELAPPLICANTINSYS THERAPEUTICS INCHIKMA PHARM CO LTDMEDEFIL INCAPOTEX INCSSSSSP,OSSSSSPSP,OYYREVIEW CLASSIFICATION505(B)(2) APPROV...
... Inc., a clinical stage biotechnology company, is engaged in the discovery and development of novel therapeutics that modulate immune responses through toll-like receptors (TLRs)in the United States. The company’...
...nice M. reichertEditor-in-chief, mAbs; Landes Bioscience; Austin, tX UsAthe transitions of antibody therapeutics to late-stage clinical development, regulatory review and the market areproceeding at a rapid pace ...
...nice M. reichertEditor-in-chief, mAbs; Landes Bioscience; Austin, tX UsAthe transitions of antibody therapeutics to late-stage clinical development, regulatory review and the market areproceeding at a rapid pace ...
Alzheimer’s Disease: Genetics, Pathogenesis, Models, and Experimental Therapeutics
Respiratory Drugs (for Asthma & COPD)Phase III/Therapeutics
... Abbott Nutrition 几十种3. Abraxis Oncology 3种 抗肿瘤-紫杉醇 4. Accera5. Access Pharmaceuticals 6. Acorda Therapeutics 7. Actavis8. Actelion Pharmaceuticals 2--心血管 9. Actient Pharmaceuticals10. Adams Respiratory The...
...cine. New York: BasicBooks, 1982. 30-59, 79-112. Over the past two weeks, we have been discussing therapeutics in the colonial period. Several issues related to therapeutics have come up. First, the medical m...
...nce to EGFR-targeted therapy.Clearly, there is an urgent and persistent motivation to develop novel therapeutics independent of the genetic background of the cancer in the ght against this deadly disease.Nanote...
...fter Drug Eluting Stent ImplantationShinsuke Nanto, M.D., PhD.Department of Advanced Cardiovascular Therapeutics Osaka University Graduate School of Medicine